Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...
News-Medical.Net on MSN
Study confirms PSA screening improves survival and safety
After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...
Junkins, who specializes in internal medicine, diligently monitored his health, including annual prostate-specific antigen checks, which consistently came back normal. “I’ve checked my PSAs and all my ...
During September’s Prostate Cancer Awareness Month, MidLantic Urology is reminding men of a critical point. It's 0.75. If your PSA increases by 0.75 in 1 year, it could be prostate cancer, and it’s ...
MedPage Today on MSN
PSA Screening Reduces Prostate Cancer Deaths, Long-Term Data Show
A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...
On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...
There is no single, diagnostic test for prostate cancer and PSA tests are not routinely used to screen healthy men because ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback